BSECompany Update▲ PositiveResults30 Oct 2026
Aditya Birla Real Estate Ltd
Transcript of Q2/H1 FY2026-27 Earning Conference Call held on 26th October, 2026
Aditya Birla Real Estate Ltd reported a strong 1HFY27 performance with total income increasing 309% Y-o-Y to INR355 crores and collections increasing 39% Y-o-Y to INR1,465 crores. The company also crossed the landmark milestone of INR10,000 crores in cumulative collection across its projects.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults30 Oct 2026
Aditya Birla Real Estate Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Aditya Birla Real Estate Limited has informed the Exchange about Transcript of Q2/H1 FY2026-27 Earnings conference call held on 26th October, 2026. The company delivered a strong 1HFY27 performance with total income increasing 309% Y-o-Y to INR355 crores and collections increasing 39% Y-o-Y to INR1,465 crores.
NSEUpdates▲ PositiveOrder Win30 Oct 2026
Timken India Limited
Updates
Timken India Limited has received two Bureau of Indian Standards (BIS) licenses for its bearings, one for Spherical Roller Bearings at its Bharuch new plant and the other for Cylindrical Roller Bearings at its Bharuch old plant. This achievement confirms the company's leadership in manufacturing excellence, quality assurance, and regulatory compliance.
NSEPress Release▲ PositiveResults30 Oct 2026
Narayana Hrudayalaya Ltd.
Press Release
Narayana Hrudayalaya Ltd. has announced its Q2 FY27 results, with consolidated operating revenue at ₹ 28,440 Mn, up 73.0% YoY, and EBITDA of ₹ 6,054 Mn, up 42.0% YoY.
BSECompany Update▲ PositiveExpansion30 Oct 2026
Infosys Ltd
Enclosed
Infosys Ltd announced the expansion of its Pocharam Development Center in Hyderabad, Telangana, with a new 1.1 million sq. ft. facility, enhancing capabilities in AI, Cloud, Cybersecurity, and next-generation digital services.
NSEPress Release▲ PositiveResults30 Oct 2026
CORONA Remedies Limited
Press Release
CORONA Remedies Limited has announced its unaudited financial results for Q2 and H1 FY27, reporting a 22.2% year-on-year growth in revenue and 22% growth in H1FY27. The company has outperformed the Indian Pharmaceutical Market (IPM) growth and has received Good Manufacturing Practice (GMP) certification from Brazil's National Health Surveillance Agency (ANVISA).
BSECompany Update▲ PositiveResults30 Oct 2026
Narayana Hrudayalaya Ltd
Press release for the quarter and half year ended September 30, 2026.
Narayana Hrudayalaya Ltd reported Q2 FY27 results with consolidated operating revenue at ₹ 28,440 Mn, up 73.0% YoY, and EBITDA of ₹ 6,054 Mn, up 42.0% YoY. India revenue grew 16.6% YoY, driven by higher patient volumes, complex procedures, and a 75.7% rise in international patient revenue.
NSEUpdates▲ PositiveExpansion30 Oct 2026
Infosys Limited
Updates
Infosys has announced the expansion of its Pocharam Development Center in Hyderabad, Telangana, with a new 1.1 million sq. ft. facility, enhancing capabilities in AI, Cloud, Cybersecurity, and next-generation digital services.
NSECredit Rating▲ Positivecredit_rating30 Oct 2026
BOROSIL RENEWABLES LIMITED
Credit Rating
BOROSIL RENEWABLES LIMITED has informed the Exchange about Credit Rating upgrade by India Ratings & Research Private Limited (India Ratings), a Credit Rating Agency, to 'IND AA-' from 'IND A, with a Stable Outlook, and short-term rating to 'IND A1+' from 'IND A1', while rating additional limits as follows: Bank loan facilities (reduced from 7,271.4) and Proposed bank loan facilities 450
BSECompany Update▲ PositiveResults30 Oct 2026
Narayana Hrudayalaya Ltd
Investor Presentation for the quarter and half year ended September 30, 2026.
Narayana Hrudayalaya Ltd has released its investor presentation for the quarter and half year ended September 30, 2026, highlighting a 73.0% YoY increase in consolidated operating revenues to ₹ 28,440 Mn and a 21.3% EBITDA margin.
BSECompany Update▲ PositiveBuyback30 Oct 2026
Medi Assist Healthcare Services Ltd
Buyback of fully paid-up equity shares of the Company through the tender offer route
Medi Assist Healthcare Services Ltd has announced a buyback of up to 11,59,199 fully paid-up equity shares at INR 425/- per share, within the limit of 10% of the aggregate of the total paid-up equity share capital and free reserves of the Company.
BSECompany Update▲ PositiveOrder Win30 Oct 2026
Timken India Ltd
In furtherance to our earlier communication dated 13 July, 2026, please find attached press release regarding BIS Licenses obtained by Timken India Limited.
Timken India Ltd has received two BIS licenses for its bearings, one for Spherical Roller Bearings at its Bharuch new plant and the other for Cylindrical Roller Bearings at its Bharuch old plant. This achievement confirms the company's leadership in manufacturing excellence, quality assurance, and regulatory compliance.
BSECompany Update▲ PositiveRating Change30 Oct 2026
Borosil Renewables Ltd
Update on Credit Rating
Borosil Renewables Ltd's bank loan facilities' long-term rating has been upgraded to 'IND AA-' from 'IND A' with a Stable Outlook, and short-term rating to 'IND A1+' from 'IND A1' by India Ratings & Research Private Limited.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults30 Oct 2026
Sunteck Realty Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Sunteck Realty Limited has informed the Exchange about Transcript of Earning Conference Call on Q2 and H1 FY 2027 Results and Business updates.
BSECompany Update▲ PositiveResults30 Oct 2026
Sunteck Realty Ltd
Transcript of Earnings Conference Call on Q2 and H1 FY 2027 Results and Business updates.
Sunteck Realty Ltd has delivered a strong first half with growth across presales, collections, cash flows, revenue and profits, sustaining the CAGR of 25% across all major operational and financial parameters over the last 5 years. The company has acquired a new land parcel of 4.5 acres at Borivali West through an outright purchase, enhancing the project scale, development potential and setting the benchmark for uber luxury living in that micro market.
BSECompany Update▲ PositiveOrder Win30 Oct 2026
Alembic Pharmaceuticals Ltd
Alembic Pharmaceuticals Limited receives USFDA Final Approval for Venetoclax Tablets, 10mg, 50 mg and 100 mg.
Alembic Pharmaceuticals Ltd has received USFDA Final Approval for Venetoclax Tablets, 10mg, 50mg, and 100mg, which are indicated for the treatment of chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and newly diagnosed acute myeloid leukemia (AML) in adults 75 years or older, or who have comorbidities that preclude use of intensive induction chemotherapy.
NSEPress Release▲ PositiveOrder Win30 Oct 2026
Alembic Pharmaceuticals Limited
Press Release
Alembic Pharmaceuticals Limited has received USFDA Final Approval for Venetoclax Tablets, 10 mg, 50 mg and 100 mg, which are therapeutically equivalent to the reference listed drug product Venclexta Tablets, 10 mg, 50 mg, and 100 mg of AbbVie Inc. This approval may make Alembic eligible for 180 days of generic drug exclusivity and has a cumulative total of 248 ANDA approvals from the USFDA.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults30 Oct 2026
Iris Clothings Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Iris Clothings Limited has reported Q2 and H1 FY '27 earnings, with total income growing 40.3% year-on-year and net profit increasing 23.3% in Q2 FY '27. The company has also announced plans to expand its distribution reach, strengthen its manufacturing capabilities, and explore new growth opportunities across domestic and international markets.
NSEOutcome of Board Meeting▲ PositiveResults30 Oct 2026
Medi Assist Healthcare Services Limited
Outcome of Board Meeting
Medi Assist Healthcare Services Limited has announced unaudited financial results for the quarter and half year ended September 30, 2026, and has approved a buyback of up to 11,59,199 equity shares at INR 425 per share.
BSECompany Update▲ PositiveRating Change30 Oct 2026
Suzlon Energy Ltd
Updates on ratings
Suzlon Energy Ltd has announced that ICRA has upgraded its ratings, with the long-term rating revised to ICRA A+ with a positive outlook, and the short-term rating reaffirmed at ICRA A1.